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Abstract Aging is associated with increased susceptibility to
microbial infections, and monocytes play an important role in
microbial defense. In this study, we have identified and
compared four subpopulations of monocytes (CD14
++(high)
CD16
−,C D 1 4
+(low)CD16
−,C D 1 4
++(high)CD16
+,a n d
CD14
+(low)CD16
+) in the peripheral blood of young and aged
subjects with regard to their numbers, cytokine production,
TLR expression, and phosphorylation of ERK1/2 in response
to pam3Cys a TLR-1/2 ligand. Proportions and numbers of
CD14
++(high)CD16
+ and CD14
+(low)CD16
+ monocytes were
significantly increased, whereas proportions of CD14
+(low)
CD16
− monocytes were decreased in aged subjects as
compared to young subjects. In aged subjects, IL-6 production
by all four subsets of monocytes was significantly decreased,
whereas TNF-α production was decreased in monocyte
subsets, except the CD14
+(low)CD16
− subset. A significantly
r e d u c e de x p r e s s i o no fT L R 1w a so b s e r v e di nC D 1 4
++(high)
CD16
+ and CD14
+(low)CD16
+ monocyte subsets in aged
subjects. Furthermore, following pam3Cys stimulation,
ERK1/2 phosphorylation was significantly lower in
CD14
+(low)CD16
+,C D 1 4
++(high)CD16
+,a n dC D 1 4
+(low)
CD16
− subsets of monocytes from aged subjects. This is the
first study of four subpopulations of monocytes in aging,
which demonstrates that their functions are differentially
impaired with regard to the production of cytokines, expres-
sion of TLR, and signaling via the ERK–MAPK pathway.
Finally, changes in the number of monocyte subsets, and
impairment of TLR1 expression, TNF-α production, and
EK1/2 phosphorylation was more consistent in CD16
+
monocyte subsets regardless of expression of CD14
high or
CD14
+low, therefore highlighting the significance of further
subdivision of monocytes into four subpopulations.
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Introduction
Aging is associated with a progressive immune deficiency
rendering aged subjects susceptible to infections and
displays impaired response to vaccination [1–3]. Mono-
cytes play an important role in defense against microbial
pathogens and inflammation [4, 5]. Heterogeneity of
monocytes is now well established. Two distinct subpopu-
lations of monocytes (CD14
++(high)CD16
− and
CD14
+(low)CD16
+) were described by Passlick et al. [6].
These two subsets of monocytes are distinct with regard to
certain cell surface molecules, migration properties, and
their functions [7–12]. CD14
++(high)CD16
− subpopulation
of monocytes expresses CD62L, CD64, and CCR2 with
low levels of CXCR1 [12]. In contrast, CD14
+(low)CD16
+
monocytes lack CD62L, CD64, or CCR2 but express high
levels of CX3CR1. CD14+CD16+ monocytes are consid-
ered pro-inflammatory monocytes since they produce
increased levels of TNF-α and low levels of anti-
inflammatory IL-10 in response to Toll-like receptors
(TLR2 and TLR-4 agonists [12–14]. Renshaw et al. [15]
reported decreased expression of all TLRs in both splenic
and activated peritoneal macrophages from aged mice as
compared to young mice. Furthermore, they demonstrated
that macrophages from aged mice secreted significantly less
IL-6 and TNF-α upon stimulation with TLR ligands.
In the present study, we report for the first time numerical
and functional analyses of four subpopulations of peripheral
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++(high)CD16
−, CD14
+(low)CD16
−,
CD14
++(high)CD16
+, and CD14
+(low)CD16
+) in young and
aged humans, and demonstrate a functional defect in TLR1/
2-induced IL-6 and TNF-α production in aged subjects,
which appears to be associated with decreased expression of
TLR1 and is likely mediated via impaired ERK–MAPK
signaling pathway.
Materials and Methods
Peripheral blood from 17 young (age 21–32 years) and 17
aged (age 66–89 years) subjects was used for the present
study. These subjects are of middle-class social status, and
aged subjects are living independent, healthy lives, and they
were asked to stop taking all anti-oxidants (which many
aged subjects take on a regular basis) for at least 1 week
prior to obtaining blood samples to avoid their effects on
the present investigation. The study is approved by
Institutional Review Board (Human) of the University of
California, Irvine.
Determination of Monocyte Subsets and the Expression
of TLR 1 and TLR2
Expression of TLR1 and TLR2 on monocyte subsets was
determined by flow cytometry using FITC- conjugated anti-
CD14, Alexa Fluor 647-labeled anti-CD16 antibodies (BD
Biosciences, San Diego, CA, USA) and PE-labeled anti-
TLR2 antibodies (e-Biosciences, San Diego, CA, USA).
Briefly, 100 μl of whole blood was incubated with 10 μlo f
each of the anti-CD14, anti-CD16, and anti-TLR1 or anti-
TLR2, or isotype control antibodies for 15 min at room
temperature in the dark. Cells were then incubated in 2 ml
of FACS lysing solution (Becton-Dickinson, San Jose, CA,
USA) for 15 min to lyse red blood cells and washed twice
with phosphate-buffered saline (1× PBS), and the cells were
resuspended in 0.5 mL of 1% paraformaldehyde and
analyzed by FACSCalibur.
Measurements of Intracellular IL-6 and TNF-α
Whole peripheral blood was activated with 5 μg/ml of
TLR1/TLR2 ligand pam3cys (Invivogen, San Diego, CA,
USA) in the presence of Brefeldin A for 4 h. After CD14/
CD16 labeling, cells were washed and permeabilized using
FACS permeabilizing solution (Becton-Dickinson), and
subsequently incubated with the appropriate PE-
conjugated anti-IL-6, anti-TNFα or isotype control anti-
body (Becton-Dickinson).
For each sample, data from 5,000 cells were collected
and analyzed using a FACScalibur flow cytometer and
CellQuest software (Becton-Dickinson). Forward and side
scatters were used to gate monocytes and to exclude
cellular debris. During analysis, an electronic gate was
placed on CD14
++ (high)CD14
+ (low)-positive cells, and the
associated expression of CD16 and TLR1 or TLR2 or
cytokines was determined by multicolor analysis. The
proportion of various subsets of monocytes (CD14
++(high)
CD16
−,C D 1 4
++(high)CD16
+,C D 1 4
+(low)CD16
−,a n d
CD14
+(low)CD16
+) expressing TLR1 and TLR2, or con-
taining intracellular IL-6 and TNF-α, were analyzed for
numbers and mean fluorescence channel number (MFC#,
indicator of the density of TLR receptors on cell surface)
Activation of ERK Kinases
To study TLR1/2-mediated signaling in monocyte subsets,
whole peripheral blood was activated with 5 μg/ml of
pam3ys for 10 min. Activation of ERK was determined by
intracellular phospho protein technique and flow cytometry
using the protocol provided by the manufacturer of
phophoflow kit (BD Biosciences). Briefly, cells were fixed
immediately following activation with pam3Cys using BD
Phosflow Lyse/Fix Buffer, permealized by adding 1ml of
Phosflow Perm/Wash Buffer to 10
7 cells, and incubated for
10 min at room temperature with the appropriate PE-
conjugated phopho ERK1/2-specific anti bodies and FITC-
conjugated anti-CD14 and Alexa 687-labeled anti-CD16
monoclonal antibodies. Cells were washed and acquired
and analyzed as described above. Fold change was
calculated by dividing the median fluorescence intensity
(MFI) of the stimulated sample (MFI stim) by that of the
unstimulated sample (MFI unstim).
Activation of ERK was also determined in purified
monocytes by Western blotting. Peripheral blood mono-
cytes from young and aged subjects were purified by using
magnetic nanobeads (Stem cell Technologie, Vancouver,
British Columbia, Canada). Monocytes were activated with
5 μg/ml of pam3Cys for 10 min, and lysed with lysing
buffer (Tris–HCl pH 7.4 20 mM, NaCl 150 mM, Triton X-
100 1.2%, EGTA 1 mM, PMSF 1 mM, aprotinin 0.15 U/ml,
leupeptin 10 μg/ml, NaN03). Protein concentration was
determined by using a protein assay kit (Bio-Rad). An
equal amount of protein was subjected to sodium dodecyl
sulfate-polyacrylamide gel electrophoresis and transblotted
onto polyvinylidene difluoride membrane (Millipore). After
blocking, phosphorylation of ERK was determined by
incubating the blot with phospho specific ERK antibodies
(Cell Signaling, Danvers, MA, USA) followed by incuba-
tion with an appropriate HRP-labeled secondary antibody.
The specific protein was detected by enhanced chemilumi-
nescence (ECL) (GE-Amersham, Piscataway, NJ, USA).
The blots were analyzed using Un-Scan-It software to
estimate the density of the bands in pixels. Actin protein
served as an internal loading control.
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Results
Four subsets of monocytes in healthy young and aged
subjects Monocyte subsets were analyzed in whole blood
samples with FITC-anti-CD14 and Alexa687-anti-CD16 mono-
clonal antibodies and isotype controls using FACSCalibur.
Figure 1a shows a representative cytoflourograph for the
analysis of four subsets of monocytes. The order of frequency
was CD14
++(high)CD16
− (major subset) >CD14
++(high)CD16
+>
CD14
+(low)CD16
−>CD14
+(low)CD16
+. Figures 1b and c show
the cumulative data for the proportions and absolute
numbers, respectively, for all four subsets of monocytes from
17 young subjects and 17 aged subjects. A significant
increase in the proportions (<0.03) and number (P<0.03)
of CD14
++(high)CD16
+, and CD14
+(low)CD16
+ monocytes,
and a significant decrease in the proportions (P<0.001)
and numbers (P<0.04) of CD14
+(low)CD16
− was observed
in aged subjects. No significant difference was observed
between young and aged subjects in the proportions or
numbers of CD14
++(high)CD16
− subset.
TLR 1/2 agonist-induced cytokine production is reduced
in aging Aging is associated with increased levels of
circulating IL-6, and TNF-α [15], and since we observed
increased numbers of monocyte subsets, we reasoned that
monocyte subsets might be the major source of increased
IL-6 and TNF-α in aging. Therefore, we examined IL-6 and
TNF-α synthesis in all four subsets of monocytes following
stimulation by pam3cys. Whole blood white blood cells
were stimulated with pam3cys in the presence of brefeldin
A to inhibit secretion of cytokines and intracellular TNF-α,
and IL-6 synthesizing cells were measured with multiple
monoclonal antibodies defining monocyte subsets and
antibodies against IL-6 and TNF-α by multicolor flow
cytometry using FACSCalibur. Figure 1a shows a repre-
sentative cytofluorgraphs of IL-6 and TNF-α producing
subsets of monocytes in a healthy young subject. TNF-α
production was significantly higher (Fig. 2b)i nb o t h
subsets of CD14
+low monocytes (CD14
+CD16
+ and
CD14
+CD16
−), as compared to two subsets of CD14
++ high
monocytes (CD14
++
CD16
+ and CD14
++CD16
−) in young
subjects. This would be in agreement with reported
increased TNF-α production by CD14
+CD16
+ monocytes
[13]; however, we did not observe any difference in IL-6
among four subsets of monocytes in young subjects
(Fig. 2c). Furthermore, all four subpopulations of mono-
cytes displayed significantly reduced (P<0.01–P<0.05) IL-
6 production in aged (Fig. 2c) as compared to young
subjects. However, the extent of decreased IL-6 production
by CD14
+low CD16
+ and CD14
++CD16
+ monocyte subset
was significantly greater (P<0.01) than decreased IL-6
production by two subsets of CD16
− monocytes (P<0.05).
TNF-α production was significantly decreased (P<0.05) in
all but CD14
+ low CD16
+ monocyte subsets in aged subjects
as compared to controls (Fig. 2b). This would suggest a
functional heterogeneity of two subpopulations of
CD14
+low monocytes.
TLR 1 expression is reduced in aged humans Since
pam3Cys stimulates both TLR 1 and TLR 2, we examined
whether decreased cytokine production in monocyte subsets
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Fig. 1 Monocyte subsets in young and aged humans. a Representa-
tive cytofluorograph of four subsets of monocytes based upon
expression of CD14 and CD16 antigens from a young subjects.
b Cumulative data for the proportions and c numbers of four subsets
of monocytes from 17 young and 17 aged subjects. Data are expressed
as mean ± SD. *P<0.05, **P<0.01
808 J Clin Immunol (2010) 30:806–813is due to altered expression of TLR1 and/or TLR-2. No
significant difference was observed in the proportions of
four subsets of monocytes expressing TLR 2, or the density
of TLR2 between young and aged subjects (data not
shown). Figure 3a shows a representative cytoflourograph
of TLR1 expression in four subsets of monocytes in a
young subject. A lower proportion of CD14
++ high CD16
+
and CD14
+ low CD16
+ monocyte subsets expressed TLR1
as compared to CD14
+CD16
− and CD14
++CD16
− in young
subjects. Figure 3b shows cumulative data for the propor-
tions of cell expressing TLR1, and Fig. 3c shows
cumulative data of the density of TLR1 (as determined by
mean fluorescence channel numbers (MFC#)) in young and
aged subjects. A significantly reduced expression of TLR 1
wasobservedin CD14
++ high CD16
+ (P<0.03) and CD14
+l o w
CD16
+ (P<0.007) from aged as compared to young subjects.
Similarly, a significantly reduced density of TLR1 was
observed in CD14
++ high CD16
+ and CD14
+l o wCD16
+
monocytes (P<0.05). Therefore, it is likely that decreased
cytokine production in aging is due to an impaired expression
of TLR 1.
Phosphorylation of ERK1/2 is reduced in aged monocytes
Protein was purified from isolated monocytes from young
and aged subjects with or without stimulation with
Pam3cys and analyzed by Western blotting using native
and phosp ERK1/2 monoclonal antibodies, and quantified
by densitometer. Figure 4a shows a representative Western
blot gel and densitometry data. Monocytes from aged
subjects displayed decreased phosphorylation of ERK1/2 as
compared to young subjects. We then examined phosphor-
ylation of ERK1/2 in all four subsets of monocytes from
young and aged subjects with native and phopho ERK1/2
antibody and multicolor flow cytometry using FACSCalibur.
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Fig. 2 Cytokine production by four subsets of monocytes in young and aged subjects. a Representative cytoflourograph of IL-6 and TNF-α
production by four subsets of monocytes from young subjects. b Cumulative data for IL-6 and c for TNF-α from young and aged subjects
J Clin Immunol (2010) 30:806–813 809Figure 4b shows a significantly decreased (P<0.05–P<
0.005) phosphorylation of ERK1/2 in CD14
+(low)CD16
+,
CD14
+(low)CD16
−, and CD14
++CD16
+ subsets of monocytes
from aged subjects as compared to young subjects. Further-
more, significantly greater reduction (P<0.005) of ERK1/2
phosphorylation was observed in CD14
+(low)CD16
− as
compared to CD14
++(high)CD16
+ (P<0.02) and
CD14
+(low)CD16
+ (P<0.05).
Discussion
In this study, we have demonstrated alterations in the
proportions and numbers, TLR1 expression, cytokine
production, and phosphorylation of ERK1/2 in subsets of
monocytes. These impairments in number and functions are
more consistent in CD16+ monocytes and did not correlate
with CD14
++high or CD14
+low, the original subdivision of
monocytes into two subsets. Therefore, this study high-
lights the need of further subdivision of monocytes in four
subsets.
Aging is associated with the progressive decline in
immune functions and increased susceptibility to microbial
infections [1–3]. Although alterations in adaptive responses
are well established, innate immune responses in human
aging are not as well understood. TLRs are pathogen
recognition receptors that recognize shared structural
components from bacteria, fungi, and viruses [16–19].
Eleven TLRs in humans and 13 TLRs in mice have been
described, and ligands for nine human TLRs are known.
Monocytes/macrophages play an important role in defense
against microbes and express several TLRs [19]. Initially,
two subpopulations of monocytes were described in human
monocytes-based expression of CD14 and CD16 mole-
cules, their migratory properties, and cytokine production
[6–12]. Kim et al. [20] described three subpopulations of
monocytes in simian immunodeficiency virus infection. In
humans, CD14
+(low)CD16
+ monocytes, by virtue of pro-
ducing higher levels of proinflammatory cytokines (IL-6
and TNF-α) as compared to CD14
(high)CD16
− monocytes,
were termed proinflammatory monocytes. In this study, we
analyzed four subpopulations of human monocytes, and we
observed that two subpopulations of CD14
(low) monocytes
(CD14
+(low)CD16
+ and CD14
+(low)CD16
−) contained in-
creased levels of TNF-α; however, we did not observe any
significant difference for IL-6 among any of the four
subsets of monocytes. A discrepancy for IL-6 between our
results and those of others may be due to difference in the
assays used. In our study, we analyzed intracellular
cytokines (synthesized) in four subsets, whereas others
have reported secreted cytokines in the culture supernatants
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Fig. 3 Expression of TLR1 on four subsets of monocytes in young
and aged subjects. Each subset of monocytes was gated, and
proportions of each subset with TLR1 expression were expressed as
percent of a particular subset of monocyte. a Representative
cytofluorograph from a young subject, b cumulative data for the
proportions of TLR-1+ subsets, and c the fluoresecence intensity of
TLR1 (mean fluorescence channel number (MFC#)) of TLR-1 in each
subset of monocytes from young and aged subjects
810 J Clin Immunol (2010) 30:806–813of two purified subsets of monocytes [10, 12]. Similar
discordant was observed for TNF-α using different meth-
ods of measurement of cytokines [13]. Belge et al. [13]
observed no difference in TNF-α mRNA between CD14
++
CD16
− and CD14
+CD16
+ monocytes (only two monocyte
subpopulations were analyzed); however, using intracellular
cytokine staining, they observed higher levels of TNF-α in
CD14
+CD16
+ subsets.
In the present study, we also analyzed four subsets of
human monocytes and their functions in aged humans.
Proportions and numbers of CD14
++(high)CD16
+ and
CD14
+(low)CD16
+ monocytes were increased in aged sub-
jects, whereas proportions and numbers of CD14
+(low)CD16
+
monocytes were decreased in aged as compared to young
subjects. There was no correlation between the changes in
proportions and numbers of monocyte subsets and TLR1
expression, cytokine production, or ERK1/2 phophorylation
(data not shown).
Aging is associated with increased levels of proinflam-
matory cytokines IL-6 and TNF-α [21, 22]. Since we
observed an increased number of monocyte subsets in
aging, we expected that monocytes may be a source of
increased IL-6 and TNF-α in aging. However, our data
show that pam3Cys (a ligand for TLR1 and TLR2)-induced
IL-6 and TNF-α-producing cells were significantly reduced
in aged monocyte subsets as compared to that of young
subjects. This is in agreement with published data for total
or two subsets of monocytes in aged subjects in response to
TLR2 and TLR4 activation [23, 24]. Furthermore, sub-
populations of CD14
+(low) monocytes (CD14
+(low)CD16
−)
had significantly fewer changes for IL-6 or no change in
TNF-α production in aged as compared to other monocyte
subsets. This observation highlights the importance of
analyzing four subpopulations of monocytes. In mice,
several investigators have reported decreased IL-6 and
TNF-α production by splenic and activated peritoneal
macrophages from aged mice activated by the ligands of
TLRs as compared to young mice [15]. However, no
significant change was observed in the expression of TLR2
ad TLR4 in aged mice as compared to young mice. van
Duin and colleagues [25] also reported reduced IL-6 and
TNF-α production by total monocyte population from aged
humans following TLR1/2 stimulation. Our study may have
an advantage and perhaps reflect more in vivo events, since
experiments were performed in whole blood and gated
subpopulations of monocytes rather than isolated mono-
cytes, as in the study of van Duin et al. [25], which may
result in a loss of a preferential subset of monocytes. In the
present study, we have measured the number of various
monocyte subsets producing cytokines in whole blood
samples rather than cytokines produced in culture super-
natants. Taken together, it appears that cells other than
monocyte subsets are the source of increased levels of IL-6
and TNF-α in aged humans. Recently, we have reported
that dendritic cells from aged subjects secrete increased
amounts of proinflammatory cytokines, and may be the cell
type contributing to the increased circulating levels of
proinflammatory cytokines in aged subjects [26].
A decreased cytokine production by monocyte subsets
may result from decreased expression of TLR1 and/or
TLR2. In aging mice, Renshaw et al. [15]r e p o r t e d
decreased expression of all TLRs mRNA as compared to
younger mice. However, we have observed that the
proportion of cells expressing TLR2, as well as the density
of TLR2 in all four subsets of monocytes from aged
subjects, was comparable to that of young subjects (data not
shown). In contrast, a significantly decreased expression of
TLR1 was observed on CD14
++(high)CD16
+ and
CD14
+(low)CD16
+ monocyte subsets from aged subjects.
Interestingly, expression of TLR1 and TLR2 on various
subsets of monocytes from young subjects was different.
TLR2 expression was significantly higher in CD14
++(high)
CD16
+ and CD14
+(low)CD16
+ as compared to CD14
++(high)
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Fig. 4 Phosphorylation of ERK1/2 in monocyte subsets from young
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− and CD14
+(low)CD16
− monocytes (data not
shown). In contrast,TLR1 expression was predominantly
on CD14
++(high)CD16
+ and CD14
+(low)CD16
+ as com-
pared to CD14
++(high)CD16
− and CD14
+(low)CD16
− mono-
cytes. No such study of TLR expression in various
monocyte subsets has been reported. van Duin et al. [25]
also reported normal TLR2 expression and decreased
T L R 1e x p r e s s i o ni nt o t a lm o n o c y t ep o p u l a t i o ni na g e d
humans.
TLR agonists induce proinflammatory cytokine secretion
via activation of ERK–MAP kinase signaling pathway [27–
29]. Kopp et al. [29] demonstrated that the activation of
adipocytes with pam3cys resulted in the secretion of IL-6,
which was dependent upon phosphorylation of ERK.
Agrawal et al. [27] reported that activation of DCs via
TLR4 and TLR5 resulted in the phosphorylation of p38 and
c-Jun N-terminal kinase 1/2 (JNK1/2), whereas activation
of DCs via pam3cys (TLR2 ligand) resulted in a sustained
phosphorylation of ERK1/2. Dillon and colleagues [28]
reported that the activation of DCs by Zymosan, a stimulus
for TLR2, resulted in the phosphorylation of ERK1/2. In
both aged mice and aged humans, macrophages/monocytes-
decreased basal levels of p38 MAPK have also been
reported [23–25]. However, no study on ERK1/2 activation
in aged monocytes has been reported. In this study, we
observed that pam3Cys-induced phosphorylation of ERK1/
2 was decreased in all subsets of monocytes in aging,
suggesting that decreased IL-6 and TNF-α synthesis in
aged humans appears to be in part due to impaired TLR1/2
signaling mediated via ERK1/2 pathway. Since TLR1/2 is a
heterodimer, which is stimulated by pan3cys, it remains to
be determined whether the signaling defect is via TLR1 or
both TLR1 and TLR2. In the present study and those
reported by van Duin et al. [25], TLR-2 expression is
comparable between young and aged subjects; therefore, it
is likely that the defect in monocyte subsets in aged humans
lies in TLR1-mediated signaling. TLR1/2 senses pathogen
recognition molecules shared by a range of pathogens in-
cluding Mycobacterium tuberculosis, Borrelia burgdorferi.
This may also explain increased susceptibility to a number
of microbes during aging, as well as poor response to
vaccination. This would be consistent with impaired
response to OspA vaccine (OspA is a ligand for TLR1/2)
against Lyme disease in the elderly, which was associated
with TLR1 defect but preserved TLR2 response [30].
In summary, human aging is associated with alterations
in the numbers of certain subpopulations of monocytes, and
impaired secretion of IL-6 and TNF-α, which appear to be
due to an impaired expression of TLR1 and signaling via
ERK1/2 pathway. Furthermore, in aged subjects, greater
and more significant changes were observed in CD16+
(independent of level of CD14 expression, CD14
++high or
CD14
+low) monocytes as compared to CD16
− monocyte
subsets (regardless of levels of CD14 expression). There-
fore, it is important to analyze monocytes into four subsets.
These defects in monocytes may play a role in increased
susceptibility to microbial pathogens and poor response to
vaccines in aged humans.
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